Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New wearable zaps bladder woes without surgery

NCT ID NCT07195656

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tests a non-implanted electrical stimulation device for women with overactive bladder (OAB). About 151 participants will use the device or take medication to see if the device safely reduces daily bathroom trips. The goal is to offer a non-surgical option for symptom relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 151 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Females, defined as a person with a uterus and cervix, ≥21 years old, with a diagnosis of OAB and symptoms for more than 6 months, as confirmed by a physician. OAB is defined by urinary urgency, usually with urinary frequency and nocturia, with or without urgency urinary incontinence with symptoms * Willing and able to comply with study required procedures and visits (e.g., maintaining consistent medication use, fluid intake, diary completion). Key Exclusion Criteria: * Systemic condition or disease that may interfere with study participation (e.g., current systemic infection, uncontrolled autoimmune disease, uncontrolled immunodeficiency disease, history of myocardial infarction, etc.) as determined by study investigator. * Not an appropriate study candidate as determined by investigator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Overactive bladder (OAB) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    15 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Adult & Pediatric Urology

    RECRUITING

    Omaha, Nebraska, 68114, United States

  • Atrium Health

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • Cedars Sinai

    RECRUITING

    Beverly Hills, California, 90211, United States

  • Chesapeake Urology

    RECRUITING

    Owings Mills, Maryland, 21117, United States

  • Comprehensive Urologic

    RECRUITING

    Barrington, Illinois, 60010, United States

  • Holy Cross Medical Group - Women's Center

    RECRUITING

    Fort Lauderdale, Florida, 33334, United States

  • INOVA

    NOT_YET_RECRUITING

    Falls Church, Virginia, 22042, United States

  • Minnesota Urology

    NOT_YET_RECRUITING

    Woodbury, Minnesota, 55125, United States

  • Sanford Health

    RECRUITING

    Sioux Falls, South Dakota, 57105, United States

  • Southern Urogynecology

    RECRUITING

    West Columbia, South Carolina, 29169, United States

  • Stanford

    RECRUITING

    Palo Alto, California, 94304, United States

  • UC Irvine

    RECRUITING

    Orange, California, 92868, United States

  • UCLA

    RECRUITING

    Los Angeles, California, 90095, United States

  • USCD

    RECRUITING

    San Diego, California, 92037, United States

  • University of Louisville

    NOT_YET_RECRUITING

    Louisville, Kentucky, 40205, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.